E1

For Cancer That Reaches the CNS, a Payer Opens a Door

Bangladesh’s Dengue Alarm Is Already Ringing

In Australia, Cancer Medicine Delays Cost More Than Time

In Australia, Cancer Medicine Delays Cost More Than Time

Neurology Is Trying to Stop Nerves Dying, Not Just Treat What Is Left

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

MS Does Not End at the Clinic Door. It Follows People Into Work, Money and Relationships.

Cancer Treatment Is an Endurance Event. Stop Waiting for Patients to Lose Function.

A Licensing Deal Is Not Access. But It Decides Whether Access Is Possible.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
